Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence
Completed · Phase 2 · Has a placebo group
Conditions studied: Atrial Fibrillation
In brief
This study is designed to evaluate the safety, tolerability and preliminary efficacy of vernakalant (oral) in subjects with sustained atrial fibrillation of greater than 72 hours and less than 6 months duration
Key facts
- Study ID
- NCT00267930
- Run by
- Advanz Pharma
- People needed
- 221
- Starts
- 2005-12-01
- Expected to finish
- 2006-08-01
- Last updated by the study team
- 2008-12-18
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- The Heart Center, P.C. — Huntsville, Alabama, United States
- Cardiovascular Consultants Medical Group, Inc. — Walnut Creek, California, United States
- Penn State Heart & Vascular Institute — Hershey, Pennsylvania, United States
- Marshfield Clinic — Marshfield, Wisconsin, United States
- Foothills Hospital — Calgary, Alberta, Canada
- Centre Hospitalier de l'Université de Montréal (CHUM) Hôtel Dieu — Montreal, Quebec, Canada
- Aalborg Sygehus Syd — Aalborg, Denmark
- Aarhus Sygehus Kardiologisk Afd. A — Aarhus, Denmark
- Bispebjerg Hospital — Copenhagen, Denmark
- Kardiologisk/endokrinologisk afd. E Frederiksberg Hospital — Frederiksberg, Denmark
- KAS Gentofte Kardiologisk Afdeling — Hellerup, Denmark
- KAS Herlev — Herlev, Denmark
- Sygehus Vendsyssel Hjorring — Hjørring, Denmark
- Medicinsk Afdeling Kolding Sygehus — Kolding, Denmark
- Roskilde Amts Sygehus Koge — Køge, Denmark
- Reinier de Graaf Gasthuis — Delft, Netherlands
- Catharina Ziekenhuis — Eindhoven, Netherlands
- Medisch Spectrum Twente — Enschede, Netherlands
- University Medical Center Groningen (UMCG) — Groningen, Netherlands
- Trial sectie Cardiologie — Heerlen, Netherlands
- Academisch Ziekenhuis Maastricht — Maastricht, Netherlands
- Stichting Sint Antonius Ziekenhuis — Nieuwegein, Netherlands
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.